Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment

NCT ID: NCT04207450

Last Updated: 2020-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-15

Study Completion Date

2019-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized, placebo-controlled, triple-blind trial aims to evaluate the effect of glutaraldehyde associated or not with 37% phosphoric acid conditioning on dentin hypersensitivity reduction after non-surgical periodontal treatment, and its durability after 15 and 30 days. desensitizing treatment. Additionally, investigate the impact of these treatments on health-related quality of life. The investigators selected patients who, after scraping and planing procedures, presented at least 2 teeth meeting the following inclusion criteria: presence of gingival recession without or with a periodontal pocket up to 5mm probing depth, which presented painful sensitivity response to tactile stimulus. and evaporative. Subjects were randomized into 3 groups: Placebo Group (GP) - Placebo Gel application followed by Placebo solution (distilled water); GPG- Placebo Gel application followed by application 5% aqueous glutaraldehyde solution; GSG - Application of 37% phosphoric acid followed by 5% aqueous glutaraldehyde solution. The sensitivity of the dental elements was evaluated by pain stimuli (tactile and evaporative) with the aid of a Visual Analog Scale (VAS). A questionnaire was applied to patients with the objective of capturing psychosocial experiences, prior to treatment and one month after its completion, to assess the impact of desensitizing treatment on health-related quality of life. Data will be collected and appropriate statistical tests will be applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentin Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Group

Placebo Gel + Placebo Solution (Distilled Water)

Group Type PLACEBO_COMPARATOR

Placebo gel

Intervention Type OTHER

Placebo gel application followed by placebo solution application (distilled water)

Placebo Gel + Glutaraldehyde (GPG)

Placebo Gel + 5% Glutaraldehyde Aqueous Solution

Group Type EXPERIMENTAL

Placebo Gel + 5% Glutaraldehyde Aqueous Solution

Intervention Type OTHER

Placebo gel followed by 5% aqueous glutaraldehyde solution

Phosphoric Acid + Glutaraldehyde (GAG)

37% Phosphoric Acid + Glutaraldehyde Aqueous Solution (GAG)

Group Type EXPERIMENTAL

Phosphoric Acid 37% + Solução aquosa de glutaraldeído a 5%

Intervention Type OTHER

37% phosphoric acid application followed by 5% aqueous glutaraldehyde solution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo gel

Placebo gel application followed by placebo solution application (distilled water)

Intervention Type OTHER

Placebo Gel + 5% Glutaraldehyde Aqueous Solution

Placebo gel followed by 5% aqueous glutaraldehyde solution

Intervention Type OTHER

Phosphoric Acid 37% + Solução aquosa de glutaraldeído a 5%

37% phosphoric acid application followed by 5% aqueous glutaraldehyde solution

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Presence of gingival recession without or with periodontal pocket up to 5mm probing depth, which presented painful sensitivity response to tactile and evaporative stimuli.

Exclusion Criteria

* Systemic diseases;
* Pulpitis;
* Carious lesions;
* Presence of restorations in selected teeth;
* Cracked enamel;
* Noncarious cervical lesions;
* Use of medication with analgesics and/or anti-inflammatories;
* Pregnant or lactating women;
* Desensitizing treatment and periodontal treatment received during three months prior to study recruitment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Federal do Para

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cecy Martins Silva

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Federal University of Para

Belém, Pará, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UFPara-006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Experimental Denture Pastes
NCT01237795 COMPLETED NA